Questionnaire study: Pulmonary Hemorrhage Management

We are a group of international neonatologists from various parts of the world with a common interest and goal of improving the knowledge and current evidence regarding pulmonary hemorrhage (PHEM).

Pulmonary hemorrhage (PHEM) is a life-threatening event in extremely premature infants. Currently, treatment of PHEM is mainly supportive. There is a lack of conclusive evidence regarding specific management strategy for PHEM because of the rarity of its occurrence and significant mortality associated with it. This leads to a wide variation in care practice across the institutions. Through our survey, we aim to identify the various therapeutic interventions used in management of PHEM.   
 
Please participate in our survey and share your input. 

This survey includes 14 questions and should not take more than 3-5 minutes of your time. Kindly complete the survey by December 31st 2021. 

Link to our survey: https://redcap.bswhealth.org/surveys/?s=JTFWWJARDD

This study is considered research and has been deemed exempt by the Methodist Healthcare IRB, San Antonio, TX on 11/22/21.

If you have any questions, please reach us at Kaashif_ahmad@mednax.com or Pratibha.Thakkar@uky.edu 

We greatly appreciate your time and response. Thank you!  
 
Sincerely, 
 
 

Kaashif Ahmad, M.D., MSc., FAAP 
Research Director of Neonatal Clinical Trials, MEDNAX 
 
Pratibha Thakkar, M.D., M.P.H 
Neonatologist, University of Kentucky